Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GEN3017 |
Synonyms | |
Therapy Description |
GEN3017 is a bispecific antibody targeting CD3 and TNFRSF8, which potentially induces T-cell activation and subsequent cytotoxicity of TNFRSF8-expressing tumor cells (Blood (2022) 140 (Supplement 1): 3153–3154). |